| Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle P Uppuluri, AK Chaturvedi, A Srinivasan, M Banerjee, ... PLoS pathogens 6 (3), e1000828, 2010 | 520 | 2010 |
| New antifungal flavonoid glycoside from Vitex negundo B Sathiamoorthy, P Gupta, M Kumar, AK Chaturvedi, PK Shukla, ... Bioorganic & medicinal chemistry letters 17 (1), 239-242, 2007 | 208 | 2007 |
| Design, synthesis, and biological evaluation of 1, 2, 3-trisubstituted-1, 4-dihydrobenzo [g] quinoxaline-5, 10-diones and related compounds as antifungal and antibacterial agents VK Tandon, DB Yadav, HK Maurya, AK Chaturvedi, PK Shukla Bioorganic & medicinal chemistry 14 (17), 6120-6126, 2006 | 186 | 2006 |
| Synthesis and biological evaluation of novel (L)-α-amino acid methyl ester, heteroalkyl, and aryl substituted 1, 4-naphthoquinone derivatives as antifungal and antibacterial agents VK Tandon, DB Yadav, RV Singh, AK Chaturvedi, PK Shukla Bioorganic & Medicinal Chemistry Letters 15 (23), 5324-5328, 2005 | 169 | 2005 |
| A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance CG Pierce, AK Chaturvedi, AL Lazzell, AT Powell, SP Saville, SF McHardy, ... npj Biofilms and Microbiomes 1 (1), 1-8, 2015 | 137 | 2015 |
| Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis AL Lazzell, AK Chaturvedi, CG Pierce, D Prasad, P Uppuluri, ... Journal of antimicrobial chemotherapy 64 (3), 567-570, 2009 | 132 | 2009 |
| Antifungal activity in triterpene glycosides from the sea cucumber Actinopyga lecanora R Kumar, AK Chaturvedi, PK Shukla, V Lakshmi Bioorganic & medicinal chemistry letters 17 (15), 4387-4391, 2007 | 110 | 2007 |
| Synthesis of (1, 4)-naphthoquinono-[3, 2-c]-1H-pyrazoles and their (1, 4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents VK Tandon, DB Yadav, AK Chaturvedi, PK Shukla Bioorganic & medicinal chemistry letters 15 (13), 3288-3291, 2005 | 106 | 2005 |
| Synthesis and biological evaluation of novel 1, 4-naphthoquinone derivatives as antibacterial and antiviral agents VK Tandon, DB Yadav, RV Singh, M Vaish, AK Chaturvedi, PK Shukla Bioorganic & medicinal chemistry letters 15 (14), 3463-3466, 2005 | 105 | 2005 |
| Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation JA Romo, CG Pierce, AK Chaturvedi, AL Lazzell, SF McHardy, SP Saville, ... MBio 8 (6), 10.1128/mbio. 01991-17, 2017 | 103 | 2017 |
| Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance P Uppuluri, AK Chaturvedi, JL Lopez-Ribot Mycopathologia 168, 101-109, 2009 | 92 | 2009 |
| Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development G Wall, AK Chaturvedi, FL Wormley Jr, NP Wiederhold, HP Patterson, ... Antimicrobial agents and chemotherapy 62 (10), 10.1128/aac. 01084-18, 2018 | 88 | 2018 |
| Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis AK Chaturvedi, A Kavishwar, GB Shiva Keshava, PK Shukla Clinical and Vaccine Immunology 12 (9), 1063-1068, 2005 | 87 | 2005 |
| Characteristics of Candida albicans Biofilms Grown in a Synthetic Urine Medium P Uppuluri, H Dinakaran, DP Thomas, AK Chaturvedi, JL Lopez-Ribot Journal of clinical microbiology 47 (12), 4078-4083, 2009 | 83 | 2009 |
| Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi NP Wiederhold, TF Patterson, A Srinivasan, AK Chaturvedi, AW Fothergill, ... Virulence 8 (2), 138-142, 2017 | 75 | 2017 |
| Synthesis of 4-hydroxy-1-methylindole and benzo [b] thiophen-4-ol based unnatural flavonoids as new class of antimicrobial agents PP Yadav, P Gupta, AK Chaturvedi, PK Shukla, R Maurya Bioorganic & medicinal chemistry 13 (5), 1497-1505, 2005 | 66 | 2005 |
| Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in … SP Saville, AL Lazzell, AK Chaturvedi, C Monteagudo, JL Lopez-Ribot Infection and immunity 76 (1), 97-102, 2008 | 64 | 2008 |
| Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents N Tewari, VK Tiwari, RP Tripathi, V Chaturvedi, A Srivastava, R Srivastava, ... Bioorganic & medicinal chemistry letters 14 (2), 329-332, 2004 | 64 | 2004 |
| Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated … SP Saville, AL Lazzell, AK Chaturvedi, C Monteagudo, JL Lopez-Ribot Clinical and Vaccine Immunology 16 (3), 430-432, 2009 | 51 | 2009 |
| In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis TVM Vila, AK Chaturvedi, S Rozental, JL Lopez-Ribot Antimicrobial agents and chemotherapy 59 (12), 7611-7620, 2015 | 47 | 2015 |
